
AMCOL Health & Beauty Solutions, Inc (HBS) is the wholly owned subsidiary of AMCOL International Corporation. Founded in 2001, as a supplier of ingredients to the personal care industry, HBS has evolved to be one of the largest topical delivery system companies in the world, and a specialty supplier of "technology solutions" to the cosmetic, personal care, dermo-cosmetic, and dermatology fields. Through using its proprietary formulations and patented microparticle delivery system technologies, the company improves the efficacy, tolerability, and aesthetics of therapies ranging from acne to topical analgesic to hyperpigmentation/melasma. Because of its proprietary technologies, HBS' clients are assured of having novel, defensable and effective products.
With over 150 active clients around the world, HBS' clients range from Fortune 100 cosmetic and pharmaceutical companies to start-up dermocosmetic companies.
HBS has crafted its capabilities to give the company the flexibility to meet the diverse needs of the varied markets its services and clients of all sizes ranging from start-ups to fortune 100 companies. Having the ability to both develop and manufacture topical products allows the company to provide a range of services including analytical methods development, formulation development including perfoming selected in-vitro studies internally, and the design and oversight of in-vivo studies, and the supply of products ranging from pre-clinical quantites to commercial scale production.
Further, the company has specifically stayed away from providing clincial services to allow it to freely collaborate with the leading clinical laboratories through the world.
Mr Kevin Cureton
Managing Director
General Management